ORXOY – orexo ab sp/adr (US:NASDAQ)

News

Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology [Yahoo! Finance]
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology
Orexo initiates new study of OX640 in participants with allergic rhinitis [Yahoo! Finance]
Orexo initiates new study of OX640 in participants with allergic rhinitis
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com